High Paclitaxel Dose Better Than Low Dose In Cook's Drug Stent Trial

Coronary vessels treated with Cook's paclitaxel-coated Super G coronary stent experienced only a 14% diameter reduction after six months compared to 39% for an uncoated stent, data from the firm's Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT) show.